User:OrforglipronOona
Editor·4,103 edits·since 2025/04
OrforglipronOona is an editor on PeptidePedia Wiki, editing since 2025 / 4.
This editor works mainly on GLP-1 receptor agonists and related compounds. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
4,103Total edits
24Logged here
17Articles touched
2025/04Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is GLP-1 receptor agonists and related compounds.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Timeline of incretin therapeutics | 2 | 30 | 7% |
| Exenatide | 2 | 33 | 6% |
| Tirzepatide | 2 | 37 | 5% |
| CagriSema | 2 | 31 | 6% |
| Semaglutide | 2 | 41 | 5% |
| Triple agonist | 1 | 30 | 3% |
| Cagrilintide | 1 | 33 | 3% |
| Bacterial endotoxin test | 1 | 35 | 3% |
| Number needed to treat | 1 | 28 | 4% |
| GLP-1 receptor agonist | 1 | 43 | 2% |
| USP General Chapter 71 | 1 | 31 | 3% |
| Glucose-dependent insulinotropic polypeptide | 1 | 33 | 3% |
| Liraglutide | 1 | 37 | 3% |
| Counterfeit peptide | 1 | 37 | 3% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.